GlassScriptPhysician profile
Austin T Yu
NPI 1265499685
$1,145.00
in general payments reported to CMS, 2019-2025
11 companies · $260 in 2025
The $260 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.40 · 2020: $25.31 · 2021: $111 · 2022: $191 · 2023: $440 · 2024: $97.81 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $253.67 | 2022-2024 | Sotyktu |
| Glaxosmithkline, LLC. | $180.11 | 2020-2025 | Bexsero, Pediarix |
| Kyowa Kirin, INC. | $146.18 | 2023 | Crysvita |
| Merck Sharp & Dohme LLC | $141.51 | 2022-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Genzyme Corporation | $124.67 | 2025 | |
| Sanofi Pasteur INC. | $105.08 | 2024-2025 | |
| Kaleo, INC. | $68.04 | 2021-2022 | |
| Cranial Technologies, INC | $59.23 | 2021-2024 | Doc Band |
| Alexion Pharmaceuticals, INC. | $24.03 | 2023 | Koselugo |
| Ultragenyx Pharmaceutical INC. | $23.08 | 2021 | |
| Allergan, INC. | $19.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.